MU researchers hone possible stroke treatment
Monday, June 25, 2012
COLUMBIA, Mo. (AP) — University of Missouri researchers have developed a potential new stroke treatment that targets an enzyme critical to brain function.
Zezong Gu is an assistant professor of pathology and anatomical sciences at the university’s School of Medicine. His research team has developed a drug that could delay the onset of a type of stroke that occurs when blood clots block blood flow to the brain.
The compound is also being studied for use on patients with a less common type of stroke that results in bleeding in the brain. The tests were performed on mice.
Gu recently published his research results in the journal Molecular Neurodegeneration. The MU scientists teamed with researchers at the University of Notre Dame.
More like this story
- Studies Find Hospitals Not Always Alerted of Incoming Stroke Patients
- Mayo Clinic Researchers Identify New Enzyme to Fight Alzheimer's Disease
- Lilly stops mid-stage Alzheimer’s drug study
- Study finds link between hearing loss and brain function decline in older adults
- Research aims to cut disparities in stroke care
Use the comment form below to begin a discussion about this content.
Please review our Policies and Procedures before registering or commenting